Alternative and complementary medical approaches in the prevention and treatment of cardiovascular disease

Current Problems in Cardiology

Volumn 30, Issue 8, 2005, Pages 383-459

  Frishman, William H ^k,l   Grattan, James G ^m   Mamtani, Ravinder ^k,l   Rahimtoola, Shahbudin H ^a,b   Alpert, Joseph S ^c   Bonow, Robert O ^d   Gersh, Bernard J ^e,f   O'Rourke, Robert A ^g   Scheinman, Melvin M ^h,i   Smith Jr , Sidney C ^h,j  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h Department of Medicine ^*  (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k NEW YORK MEDICAL COLLEGE   (United States)

^l WESTCHESTER MEDICAL CENTER   (United States)

^m TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; ALPHA TOCOPHEROL; ARGININE; BERBERINE; BETA CAROTENE; CARDIAC GLYCOSIDE; CARNITINE; CAROTENOID; CHROMIUM; CHROMIUM PICOLINATE; CRATAEGUS EXTRACT; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HIRSUTINE; MAGNESIUM; MEVINOLIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PANAX NOTOGINSENG EXTRACT; RAUWOLFIA EXTRACT; RESERPINE; RHYNCHOPHYLLINE; ROSMARINUS OFFICINALIS EXTRACT; TAURINE; TETRAMETHYLPYRAZINE; TETRANDRINE; UBIDECARENONE; UNINDEXED DRUG; VERATRUM ALKALOID; VITAMIN; DRUG DERIVATIVE; UBIQUINONE;

ABDOMINAL DISCOMFORT; ACANTHOSIS NIGRICANS; ACUPUNCTURE; ADD ON THERAPY; AESCULUS HIPPOCASTANUM; ALTERNATIVE MEDICINE; ANGINA PECTORIS; ANTICOAGULATION; ANTIOXIDANT ACTIVITY; ASTHMA; ATHEROSCLEROSIS; BEHAVIOR THERAPY; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARNITINE DEFICIENCY; CHINESE MEDICINE; CLINICAL TRIAL; COMMIPHORA; CONGESTIVE HEART FAILURE; CRATAEGUS; DEPRESSION; DIARRHEA; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG MEGADOSE; EXERCISE; FLUSHING; FOOD AND DRUG ADMINISTRATION; GARLIC; GASTROINTESTINAL SYMPTOM; GINKGO BILOBA; HEADACHE; HEALTH CARE DELIVERY; HEART INFARCTION; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; INOTROPISM; INSOMNIA; KIDNEY FAILURE; LINGUSTICUM WALLICHII; LIVER TOXICITY; LOW DRUG DOSE; MAGNESIUM DEFICIENCY; MAGNETIC FIELD; MANIPULATIVE MEDICINE; MASSAGE; MEDICINAL PLANT; MEDITATION; MITRAL VALVE PROLAPSE; MONASCUS; MONASCUS PURPUREUS; MUSIC THERAPY; NAUSEA; NONHUMAN; NOSE CONGESTION; PANAX NOTOGINSENG; PRURITUS; PSYCHOPHYSIOLOGY; PSYCHOTHERAPY; QUALITY OF LIFE; RAUWOLFIA; REVIEW; RHABDOMYOLYSIS; ROSEMARY; SAUNA; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; SPINAL CORD STIMULATION; STEPHANIA TETRANDRA; STOMACH ACID SECRETION; STROKE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SUICIDAL BEHAVIOR; TAI CHI; TREATMENT OUTCOME; UNCARIA; UNCARIA RHYNCHOPHYLLA; VASODILATATION; VEIN INSUFFICIENCY; VERATRUM; YOGA; CLASSIFICATION; METHODOLOGY; RELAXATION TRAINING;

CARDIOVASCULAR DISEASES; COMPLEMENTARY THERAPIES; HUMANS; MEDICINE, HERBAL; MIND-BODY AND RELAXATION TECHNIQUES; UBIQUINONE; VITAMINS;

EID: 85058203381     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2005.01.004     Document Type: Editorial

References (275)

1. D.M. Eisenberg, R.C. Kessler, C. Foster Unconventional medicine in the United States N Engl J Med 328 1993 246 252
2. M.W. Krucoff, R. Liebowitz, J.H.K. Vogel Complementary and alternative medicine therapy in cardiovascular care V. Fuster R.W. Alexander R.A. O'Rourke Hurst's The Heart 11th ed. 2004 McGraw-Hill New York, NY 2463 2472
3. W.H. Frishman, W.-N. Lee, S.P. Glasser The placebo effect in cardiovascular disease W.H. Frishman E.H. Sonnenblick D.A. Sica Cardiovascular Pharmacotherapeutics 2nd ed. 2003 McGraw-Hill New York, NY 15 25
4. H. Walach, W.B. Jonas Placebo research the evidence base for harnessing self-healing capacities J Alt Comp Med 10 Suppl. 1 2004 S103 S112
5. C.D. Morris, S. Carson Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 139 2003 56 70
6. W.H. Frishman, S.T. Sinatra, N. Kruger Nutriceuticals and cardiovascular illness W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 58 85
7. W.H. Frishman Nutriceuticals as treatments for cardiovascular disease (editorial) Heart Dis 1 1999 51
8. E.R. Miller III, R. Pastor-Barriuso, D. Dalal Meta-analysis high-dosage vitamin E supplementation may increase all-cause mortality Ann Intern Med 142 2005 37 46
9. W.H. Frishman, N.A. Kruger, D.U. Nayak Antioxidant vitamins and enzymatic and synthetic oxygen-derived free-radical scavengers in the prevention and treatment of cardiovascular disease W.H. Frishman E.H. Sonnenblick D.A. Sica Cardiovascular Pharmacotherapeutics 2nd ed. 2003 McGraw-Hill New York, NY 407 427
10. W.A. Pryor Vitamin E and heart tissue basic science to clinical intervention trials Free Radic Biol Med 28 2000 141 164
11. J.M. Rapola, J. Virtamo, J.K. Haukka Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial JAMA 275 1996 693 698
12. N.G. Stephens, A. Parsons, P.M. Schofield Randomized controlled trial of vitamin E in patients with coronary disease Cambridge Heart Antioxidant Study Lancet 347 1996 781 786
13. S. Yusuf, P. Sleight, J. Pogue Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
14. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardioco Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction Results of the GISSI Prevenzione trial Lancet 354 1999 447 455
15. I. Jialal, M. Traber, S. Deveraj Is there a vitamin E paradox? Curr Opin Lipidol 12 2001 49 53
16. J.M. Rapola, J. Virtamo, S. Ripatti Randomized trial of alpha-tocopherol and beta carotene supplements on incidence of major coronary events in men with previous myocardial infarction Lancet 349 1997 1715 1720
17. D.P. Vivekananthan, M.S. Penn, S.K. Sapp Use of antioxidant vitamins for the prevention of cardiovascular disease meta-analysis of randomized trials Lancet 361 2003 2017 2023
18. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of antioxidant vitamin supplement in 20,536 high-risk individuals a randomized placebo-controlled trial Lancet 360 2002 23 33
19. P. Shekelle, S.C. Morton, L.K. Jungvig Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease J Gen Intern Med 19 2004 380 389
20. S.B. Kritchevsky, T. Shimakawa, G.S. Tell Dietary antioxidants and carotid artery wall thickness the ARIC Study Circulation 92 1995 2142 2150
21. S.K. Osganian, M.J. Stampfer, E. Rimm Vitamin C and risk of coronary heart disease in women J Am Coll Cardiol 42 2003 246 252
22. K.T. Kaw, S. Bingham, A. Welch Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk Prospective Study a prospective population study Lancet 357 2001 657 663
23. H.H. Ting, M.A. Creager, P. Ganz Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia Circulation 95 1997 2617 2622
24. N.A. Kruger, W.H. Frishman, J. Hussain Fish oils, the B vitamins and folic acid as cardiovascular protective agents W.H. Frishman E.H. Sonnenblick D.A. Sica Cardiovascular Pharmacotherapeutics 2nd ed. 2003 McGraw-Hill New York, NY 381 405
25. P. Chan, T.Y. Huang, Y.J. Chen Randomized, double-blind, placebo-controlled study of the safety and efficacy of vitamin B complex in the treatment of nocturnal leg cramps in elderly patients with hypertension J Clin Pharmacol 38 1998 1151 1154
26. K.S. McCully Vascular pathology of homocysteinemia implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1969 111 128
27. J. Selhub, P.F. Jacques, A.G. Bostom Association between plasma homocysteine concentrations and extracranial carotid artery disease N Engl J Med 332 1995 286 291
28. R.M. Malinow, J. Nieto, M. Szklo Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults The Atherosclerosis Risk in Communities Study Circulation 87 1993 1107 1113
29. P.M. Ridker, J.E. Manson, J.E. Buring Homocysteine and risk of cardiovascular disease among post-menopausal women JAMA 281 1999 1817 1821
30. R. Rodrigo, W. Passalacqua, J. Araya Homocysteine and essential hypertension J Clin Pharmacol 43 2003 1299 1306
31. M.K. Al-Obaidi, P.J. Stubbs, P. Collinson Elevated homocysteine levels are associated with ischemic myocardial injury in acute coronary syndrome J Am Coll Cardiol 36 2000 1217 1222
32. Lowering plasma homocysteine Med Lett 45 2003 85 86
33. J.F. Toole, M.R. Malinow, L.E. Chambless Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial JAMA 291 2004 565 575
34. G.J. Hankey, J.W. Eikeboom Homocysteine and vascular disease Lancet 354 1999 407 413
35. C.D. Meyers, M.C. Carr, S. Park, J.D. Brunzell Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia Ann Intern Med 139 2003 996 1002
36. J.M. Morgan, D.M. Capuzzi, J.R. Guyton A new extended-release niacin (Niaspan):efficacy, tolerability, and safety in hypercholesterolemic patients Am J Cardiol 82 1998 29U 34U
37. A. Goldberg, P. Alagona Jr, D.M. Capuzzi Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia Am J Cardiol 85 2000 1100 1105
38. A.C. Goldberg Clinical trial experience with extended-release niacin (Niaspan) dose escalation study Am J Cardiol 82 1998 35U 38U
39. M. Seed, B. O'Connor, N. Perombelon The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover Atherosclerosis 101 1993 61 68
40. E.R. Greenberg, J.A. Baron, M.R. Karagas Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation JAMA 275 1996 699 703
41. F.K. Gey, P. Puska Plasma vitamin E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology Ann NY Acad Sci 570 1989 268 282
42. A.F. Kardinaal, F.J. Kok, J. Ringstad Antioxidants in adipose tissue and risk of myocardial infarction The EURAMIC Study Lancet 342 1993 1379 1384
43. The Alpha-Tocopherol, Beta-Carotene Therapy Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1994 1029 1035
44. G.S. Omenn, G.E. Goodman, M.D. Thornquist Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease N Engl J Med 334 1996 1150 1155
45. C.H. Hennekens, J.E. Buring, J.E. Manson Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 334 1996 1145 1149
46. S. Maxwell, A. Cruickshank, D. Thorpe Red wind and antioxidant activity in serum Lancet 344 1994 193 194
47. M.C. Hertog, E.J. Feskens, P.C. Hollman Dietary antioxidant flavonoids and risk of coronary heart disease The Zutphen Elderly Study Lancet 342 1993 1007 1011
48. J.E. Freedman, C. Parker 3rd, L. Li Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release Circulation 103 2001 2792 2798
49. S.J. Duffy, J.F. Keaney, M. Holbrook Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease Circulation 104 2001 151 156
50. G.D. Plotnick, M.C. Corretti, R.A. Vogel Effect of supplemental phytonutrients on impairment of flow-mediated brachial artery vasoactivity after a single high-fat meal J Am Coll Cardiol 41 2003 1744 1749
51. E.B. Rimm, M.B. Katan, A. Ascherio Relation between intake of flavonoids and risk for coronary heart disease in male health professionals Ann Intern Med 125 1996 384 389
52. W.H. Frishman, A. DelVecchio, S. Sanal Cardiovascular manifestations of substance abuse. Part 2: Alcohol, amphetamines, heroin, cannabis, caffeine Heart Dis 5 2003 253 271
53. D.A. Sica, W.H. Frishman, E. Cavusoglu Magnesium, potassium, and calcium as potential cardiovascular disease therapies W.H. Frishman E.H. Sonnenblick D.A. Sica Cardiovascular Pharmacotherapeutics 2nd ed. 2003 McGraw-Hill New York, NY 177 189
54. R.M. McLean Magnesium and its therapeutic uses a review Am J Med 96 1994 63 76
55. M. Shechter Oral magnesium in coronary artery disease fresh insight on thrombus inhibition Magn Rep 1999 1 4
56. M. Shechter, C.N. Merz, M. Paul-Labrador Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease Am J Cardiol 84 1999 152 156
57. B. Lichodziejewska, J. Klos, J. Rezler Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation Am J Cardiol 79 1997 768 772
58. B.S. Kendler Recent nutritional approaches to the prevention and therapy of cardiovascular disease Prog Cardiovasc Nurs 12 1997 3 23
59. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial) randomized controlled trial Lancet 363 2004 439 445
60. R.G. Lefavi, D. Wilson, R.E. Keith Lipid lowering effects of a dietary chromium (III)-nicotinic acid complex in male athletes Nutr Res 13 1993 239 249
61. H.G. Preuss, D. Wallerstedr', N. Talpur Effects of niacin-bound chromium and grape seed proanthocyanidins extract on the lipid profile of hypercholesterolemic subjects a pilot study J Med 31 5&6 2000 227 246
62. S.M. Grundy Cholesterol management in the era of managed care Am J Cardiol 85 2000 3A 9A
63. D.S. McLaren Vitamin deficiency, toxicity and dependency R. Berkow A.J. Fletcher P.K. Bondy The Merck Manual 16th ed. 1992 Merck Research Labs Rahway, NJ
64. S. Salvini, C.H. Hennekens, J.S. Morris Plasma levels of the antioxidant selenium and risk of myocardial infarction among US physicians Am J Cardiol 76 1995 1218 1221
65. F.J. Kok, A. Hofman, J.C.M. Witteman Decreased selenium levels in acute myocardial infarction JAMA 261 1989 1161 1164
66. J.T. Salonen, R. Salonen, K. Seppanen Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis BMJ 302 1991 756 760
67. B. Kuklinski, E. Weissenbacher, A. Fahnrich Coenzyme Q10 and antioxidants in acute myocardial infarction Mol Aspects Med 15 1994 S143 S147
68. P.H. Langsjoen, A.M. Langsjoen Overview of the use of CoQ10 in cardiovascular disease Biofactors 9 1999 273 284
69. E.G. Bliznakov, D.J. Wilkins Biochemical and clinical consequences of inhibiting coenzyme Q biosynthesis by lipid-lowering HMG-CoA reductase inhibitors (statins) a critical overview Adv Ther 15 1998 218 226
70. T.A. Mori, D.Q. Bao, V. Burke Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans Hypertension 34 1999 253 260
71. D. Kenny, D.C. Warltier, J.A. Pleuss Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men Am J Cardiol 70 1992 1347 1352
72. M. Kestin, P. Clifton, G.B. Belling N-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants Am J Clin Nutr 51 1990 1028 1034
73. A. Leaf, M.B. Jorgensen, A.K. Jacobs Do fish oils prevent restenosis after coronary angioplasty? Circulation 90 1994 2248 2257
74. G.J. Dehmer, J.J. Popma, E.K. van den Berg Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids N Engl J Med 319 1988 733 740
75. J. O'Keefe, W. Harris Omega-3 fatty acids Time for clinical implementation? Am J Cardiol 85 2000 1239 1241
76. C.M. Albert, C.H. Hennekens, C.J. O'Donnell Fish consumption and risk of sudden cardiac death JAMA 279 1998 23 28
77. A. Siani, E. Pagano, R. Iacone Blood pressure and metabolic changes during dietary L-arginine supplementation in humans Am J Hypertens 13 2000 547 551
78. H. Drexler, A.M. Zeiher, K. Meinzer Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine Lancet 338 1991 1546 1550
79. K. Egashira, Y. Hirooka, T. Kuga Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms Circulation 94 1996 130 134
80. Y. Hirooka, K. Egashira, T. Imaizumi Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans J Am Coll Cardiol 24 1994 948 955
81. D.J. Stewart, J. Holtz, E. Bassenge Long-term nitroglycerin treatment effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs Circulation 75 1987 847 856
82. R.C. Candipan, B. Wang, R. Buitrago Regression or progression. Dependency on vascular nitric oxide Arteriothromb Vasc Biol 16 1996 44 50
83. R.W. Jeremy, J. McCarron, D. Sullivan Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilation in the hypercholesterolemic rabbit. Response according to treatment duration, anatomic site and sex Circulation 94 1996 498 506
84. A. Quyyumi, N. Dakak, J. Diodati Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation J Am Coll Cardiol 30 1997 1220 1227
85. A. Lerman, J.C. Burnett Jr, S.T. Higano Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans Circulation 97 1998 2123 2128
86. A. Blum, L. Hathaway, R. Mincemoyer Oral L-arginine in patients with coronary artery disease on medical management Circulation 101 2000 2160 2164
87. J. Loscalzo, G. Welch Nitric oxide and its role in the cardiovascular system Prog Cardiovasc Dis 38 1995 87 104
88. A. Quyyumi Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine J Am Coll Cardiol 32 1998 904 911
89. G.Y. Oudit, M.G. Trivieri, N. Khaper Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload marine model Circulation 109 2004 1877 1885
90. A.M. Safi, R.A. Stein Role of nutriceutical agents in cardiovascular diseases an update-Part I Cardiovasc Rev Rep 24 2003 382 385
91. E. Pasini, C. Opasich, O. Pastoris Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure Am J Cardiol 93 8A 2004 41A 43A
92. R. Scognamiglio, A. Avogaro, C. Negut. Early myocardial dysfunction in the diabetic heart current research and clinical applications Am J Cardiol 93 8A 2004 17A 20A
93. E. Pasini, T.M. Scarabelli, G. D'Antona Effect of amino acid mixture on the isolated ischemic heart Am J Cardiol 93 8A 2004 30A 34A
94. T.M. Scarabelli, E. Pasini, A. Stephanou. Nutritional supplementation with mixed essential amino acids enhances myocycte survival, preserving mitochondrial functional capacity during ischemia-reperfusion injury Am J Cardiol 93 8A 2004 35A 40A
95. W.H. Frishman, S.T. Sinatra, M. Moizuddin The use of herbs for treating cardiovascular disease Sem Integr Med 2 2004 23 35
96. S.T. Sinatra, W.H. Frishman, S.J. Peterson Use of alternative medicines in treating cardiovascular disease W.H. Frishman E.H. Sonnenblick D.A. Sica Cardiovascular Pharmacotherapeutics Manual 2nd ed. 2004 McGraw-Hill New York, NY 485 512
97. W.H. Frishman, S.T. Sinatra, M. Moizuddin Herbal approach to cardiac disease W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 86 106
98. P. Goldman Herbal medicines today and the roots of modern pharmacology Ann Intern Med 135 2001 594 600
99. S.T. Sinatra, W.H. Frishman, S.J. Peterson Use of alternative/ complementary medicine in treating cardiovascular disease W.H. Frishman E.H. Sonnenblick D.A. Sica Cardiovascular Pharmacotherapeutics 2nd ed. 2003 McGraw-Hill New York, NY 857 874
100. N.R. Slifman, W.R. Obermeyer, S.M. Musser Contamination of botanical dietary supplements by Digitalis lanata N Engl J Med 339 1998 806 811
101. D.J. Radford, A.D. Gillies, J.A. Hinds Naturally occurring cardiac glycosides Med J Aust 144 1986 540
102. X.-H. Zeng, X.-J. Zeng, Y.-Y. Li Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 92 2003 173 176
103. Rauwolfia alkaloids USP DI, Vol I: Drug Information for the Health Care Professional 16th ed. 1996 United States Pharmacopeial Convention Rockville, MD
104. M.C. Sutter, Y.X. Wang Recent cardiovascular drugs from Chinese medicinal plants Cardiovasc Res 27 1993 1891 1901
105. K. Kawashima, T. Hayakawa, Y. Miwa Structure and hypotensive activity relationships of tetrandrine derivatives in stroke-prone spontaneously hypertensive rats Gen Pharmacol 21 1990 343 347
106. P. Ody The Complete Medicinal Herbal 1993 Dorling Kindersley New York, NY
107. T. Kuramochi, J. Chu, T. Suga Gou-teng (from Uncaria rhynchophylla Miquel) induced endothelium-dependent and independent relaxations in the isolated rat aorta Life Sci 54 1994 2061 2069
108. Q. Chang, Z. Zuo, F. Harrison Hawthorn J Clin Pharmacol 42 2002 605 612
109. J. Vibes, B. Lasserre, J. Gleye Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (hawthorn) flower heads Prostaglandins Leukot Essent Fatty Acids 50 1994 173 175
110. S. Shanthi, K. Parasakthy, P.D. Deepalakshmi Hypolipidemic activity of tincture of Crataegus in rats Indian J Biochem Biophys 31 1994 143 146
111. Y. Nasa, H. Hashizume, A.N. Hoque Protective effect of Crataegus extract on the cardiac mechanical dysfunction in isolated perfused working rat heart Arzneimittelforschung 43 1993 945 949
112. C. Roddewig, H. Hensel Reaction of local myocardial blood flow in non-anesthetized dogs and anesthetized cats to the oral and parenteral administration of a Crataegus fraction (oligomere procyanidines) [German] Arzneimittelforschung 27 1977 1407 1410
113. K.L. Baughman, D.J. Bradley Hawthorn extract is it time to turn over a new leaf? Am J Med 114 2003 700 701
114. M.H. Pittler, K. Schmidt, E. Ernst Hawthorn extract for treating chronic heart failure meta-analysis of randomized trials Am J Med 114 2003 665 674
115. K. Aaronson HERB CHF (Hawthorn Extract Randomized Blinded Chronic HF Study) presented at the 8th Annual Scientific Meeting of the Heart Failure Society of America 2004 September 12-15, Toronto, Canada.
116. C.J. Holubarsch, W.S. Colucci, T. Meinertz Survival and prognosis Investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)-rationale, study design and study protocol Eur J Heart Fail 2 2000 431 437
117. M. Schussler, J. Holzl, U. Fricke Myocardial effects of flavonoids from Crataegus species Arzneim Forsch 45 1995 842 845
118. W. Zhang, J. Wojta, B.R. Binder Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells Arterioscler Thromb 14 1994 1040 1046
119. S.G. Lin, X.L. Zheng, Q.Y. Chen Effect of Panax notoginseng saponins on increased proliferation of cultured aortic smooth muscle cells stimulated by hypercholesterolemic serum Chung Kuo Yao Li Hsueh Pao 14 1993 314 316
120. R.T. Ackermann, C.D. Mulrow, G. Ramirez Garlic shows promise for improving some cardiovascular risk factors Arch Intern Med 161 2001 813 824
121. C.A. Silagy, H.A. Neil A meta-analysis of the effect of garlic on blood pressure J Hypertens 12 1994 463 468
122. C. Silagy, A. Neil Garlic as a lipid lowering agent-a meta-analysis J R Coll Physicians Lond 28 1994 39 45
123. V.E. Tyler Herbs of choice V.E. Tyler The Therapeutic Use of Phytomedicinals 1994 Pharmaceutical Product Press New York, NY
124. F.H. Mader Treatment of hyperlipidaemia with garlic-powder tablets Evidence from the German Association of General Practitioners multicentric placebo-controlled, double-blind study Arzneimittelforschung 40 1990 1111 1116
125. S. Warshafsky, R. Kamer, S. Sivak Effect of garlic on total serum cholesterol Ann Intern Med 119 1993 599 605
126. T. Low Dog Herbs in cardiovascular diseases. Botanical Medicine in Modern Clinical Practice 8th Annual Course 2003 Columbia University New York June 9-13
127. J.J. Stevermer, E.J. Lindbloom Ginkgo biloba for dementia J Fam Pract 46 1998 20
128. P.R. Solomon, F. Adams, A. Silver Ginkgo for memory enhancement. A randomized controlled trial JAMA 288 2002 835 840
129. E. Ernst The risk-benefit profile of commonly used herbal therapies Ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava Ann Intern Med 136 2002 42 53
130. M.H. Pittler, E. Ernst Ginkgo Biloba extract for the treatment of intermittent claudication a meta-analysis of randomized trials Am J Med 108 2000 276 281
131. S. Vale Subarachnoid haemorrhage associated with Ginkgo biloba Lancet 352 1998 36
132. M.K. Matthews Association of Ginkgo biloba with intracerebral hemorrhage Neurology 50 1998 1933 1934
133. J. Rowin, S.L. Lewis Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion Neurology 46 1996 1775 1776
134. L. Gianni, W.B. Dreitlein Some popular OTC herbals can interact with anticoagulant therapy US Pharm 23 1998 80
135. E.A. Offord, K. Mace, C. Ruffieux Rosemary components inhibit benzo(a)pyrene-induced genotoxicity in human bronchial cells Carcinogenesis 16 1995 2057 2062
136. H. Haraguchi, T. Saito, N. Okamura Inhibition of lipid peroxidation and superoxide generation by diterpenoids from Rosmarinus officinalis Planta Med 61 1995 333 336
137. J.V. Larrondo, M. Agut, M.A. Calvo-Torras Antimicrobial activity of essences from labiates Microbios 82 1995 171 172
138. A.A. al-Hader, Z.A. Hasan, M.B. Aqel Hyperglycemic and insulin release inhibiting effects of Rosmarinus officinalis J Ethnopharmacol 43 1994 217 221
139. V.E. Tyler The Honest Herbal A Sensible Guide to the Use of Herbs and Related Remedies 3rd ed. 1993 Pharmaceutical Product Press New York, NY
140. C. Diehm, D. Vollbrecht, K. Amendt Medical edema protection-clinical benefit in patients with chronic deep vein incompetence a placebo controlled double blind study Vasa 21 1992 188 192
141. W. Lang Studies on the percutaneous absorption of 3H-aescin in pigs Res Exp Med 169 1977 175 187
142. E. Bouskela, F.Z. Cyrino, G. Marcelon Possible mechanisms for the inhibitory effect of Ruscus extract on increased microvascular permeability induced by histamine in hamster cheek pouch J Cardiovasc Pharmacol 24 1994 281 285
143. E. Bouskela, F.Z. Cyrino, G. Marcelon Possible mechanisms for the venular constriction elicited by Ruscus extract on hamster cheek pouch J Cardiovasc Pharmacol 24 1994 165 180
144. E. Bouskela, F.Z. Cyrino, G. Marcelon Effects of Ruscus extract on the internal diameter of arterioles and venules of the hamster cheek pouch microcirculation J Cardiovasc Pharmacol 22 1993 221 224
145. D. Berg Venous constriction by local administration of ruscus extract (German) Fortschr Med 108 1990 473 476
146. D. Berg Venous tonicity in pregnancy varicose veins (German) Fortschr Med 110 1992 67 71
147. Y.P. Li, Y.M. Wang Evaluation of tussilagone a cardiovascular respiratory stimulant isolated from Chinese herbal medicine Gen Pharmacol 19 1988 261 263
148. P.G. Shekelle, M.L. Hardy, S.C. Morton Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance. A meta-analysis JAMA 289 2003 1537 1545
149. P.B. Fontanarosa, D. Rennie, C.D. DeAngelis The need for regulation of dietary supplements-lessons from ephedra (editorial) JAMA 289 2003 1568 1570
150. D. Samenuk, M.S. Link, M.K. Homoud Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine Mayo Clin Proc 77 2002 12 16
151. Commentary American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra Clin Pharmacol Ther 74 2003 403 405
152. S.F. Gardner, A.M. Franks, B.J. Gurley Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers Am J Cardiol 91 2003 1510 1513
153. S. Bent, T.N. Tiedt, M.C. Odden The relative safety of ephedra compared with other herbal products Ann Intern Med 138 2003 468 471
154. T.Y.K. Chan, J.C.N. Chan, B. Tomlinson Chinese herbal medicines revisited the Hong Kong perspective Lancet 342 1993 1532 1534
155. R.S. Horowitz, K. Feldhaus, R.C. Dart The clinical spectrum of Jin Bu Huan toxicity Arch Intern Med 156 1996 899 903
156. W.H. Frishman, L.H. Opie, D.A. Sica Adverse cardiovascular drug interactions and complications V. Fuster R.W. Alexander R.A. O'Rourke Hurst's The Heart 11th ed. 2004 McGraw-Hill New York, NY 2169 2188
157. Z. Wang, C. Gorski, M.A. Hamman The effects of St. John's Wort (Hypericum perforatum) on human cytochrome P450 activity Clin Pharmacol Ther 70 2001 317 326
158. C. Tannergran, H. Engman, L. Knutson St. John's wort decreases the bioavailability of R- and S-verapamil through induction of first-pass metabolism Clin Pharmacol Ther 75 2004 298 309
159. E. Ernst The risk-benefit profile of commonly used herbal therapies ginkgo, St. John's wort, ginseng, Echinacea, saw palmetto and kava Ann Intern Med 136 2002 42 53
160. C.-S. Yuan, G. Wei, L. Dey Brief communications American ginseng reduces warfarin's effect in healthy patients Ann Intern Med 141 2004 23 27
161. S.C. Mueller, B. Uehleke, H. Woehling Effect of St. John's wort dose and preparations on the pharmacokinetics of digoxin Clin Pharmacol Ther 75 2004 546 557
162. J.G. Grattan Mind-body approach to cardiac illness W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 108 126
163. D.K. Reibel, J.M. Greeson, G.C. Brainard Mindfulness-based stress reduction and health-related quality of life in a heterogeneous patient population Gen Hosp Psychiatry 23 2001 183 192
164. J.D. Teasdale, Z.V. Segal, J.M. Williams Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy J Consult Clin Psychol 68 2000 615 623
165. R.H. Schneider, S.I. Nidich, J.W. Salerno Lower lipid Peroxide levels in practitioners of Transcendental Meditation program Psychosom Med 60 1998 38 41
166. C. Cunningham, S. Brown, J.C. Kaski Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome Am J Cardiol 85 2000 653 655
167. D. Patel, M.G. Marmot, D.J. Terry Trial of relaxation in reducing coronary risk four year follow up Br Med J (Clin Res Ed) 290 1985 1103 1106
168. M.S. King, T. Carr, C. D'Cruz Transcendental meditation, hypertension and heart disease Aust Fam Physician 31 2002 164 168
169. R.L. Harmon, M.A. Myers Prayer and meditation as medical therapies Phys Med Rehabil Clin N Am 10 1999 651 662
170. A. Al, R.E. Dunkle, C. Peterson, S.F. Bolling The role of private prayer in psychological recovery among midlife and aged patients following cardiac surgery Gerontologist 38 1998 591 601
171. W.S. Harris, M. Gowda, J.W. Kolb A randomized controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit Arch Intern Med 159 1999 2273 2278
172. J.M. Aviles, S.E. Wheelan, D.A. Hernke Intercessory prayer and cardiovascular disease progression in a coronary care unit population a randomized controlled trial Mayo Clin Proc 76 2001 1192 1198
173. M.W. Krucoff, S.W. Crater, C.L. Green Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes monitoring and actualization of noetic training (MANTRA) feasibility pilot Am Heart J 142 2001 760 767
174. M.W. Krucoff The MANTRA study project first look at MANTRA II results, Presentation 2003 American College of Cardiology Big Island Hawaii October
175. M.A. Richardson, J. Post-White, E.A. Grimm Coping, life attitudes and immune responses to imagery and group support after breast cancer treatment Altern Ther Health Med 3 1997 62 70
176. D. Spiegel, R. Moore Imagery and hypnosis in the treatment of cancer patients Oncology 11 1997 1179 1189
177. A.E. Fass Hypnosis for the relief of cardiac symptomatology W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 127 134
178. H. Benson, F.H. Frankel, R. Apel Treatment of anxiety a comparison of the usefulness of self-hypnosis and a meditational relaxation technique. An overview Psychother Psychosom 30 1978 229 242
179. G. DeBenedittis, M. Cigada, A. Bianchi Autonomic changes during hypnosis a heart rate variability power spectrum analysis as a marker of sympatho-vagal balance Int J Clin Exp Hypn 42 1994 140 152
180. J.A. Blumenthal, M. Babyak, J. Wei Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men Am J Cardiol 89 2002 164 168
181. J.A. Blumenthal, W. Jiang, M.A. Babyak Stress management and exercise training in cardiac patients with myocardial ischemia Arch Int Med 157 1997 2213 2223
182. E.J. Burker, M. Fredrikson, N. Rifai Serum lipids, neuroendocrine, and cardiovascular responses to stress in men and women with mild hypertension Behav Med 19 1994 155 161
183. E. Dusseldorp, T. van Elderen, S. Maes A Meta-analysis of psychoeducational programs for coronary heart disease patients Health Psychol 18 1999 506 519
184. R.H. Schneider, F. Staggers, C.N. Alexander A randomized controlled trial of stress reduction for hypertension in older African Americans Hypertension 26 1995 820 827
185. A. McGrady Biofeedback in cardiovascular disease W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 135 150
186. M. Schwartz, F. Andrasik Biofeedback. A Practitioner's Guide 3rd Ed. 2003 Guilford Press New York, NY
187. P. Lehrer, R.L. Woolfolk Principles and Practice of Stress Management 2nd Ed. 1993 Guilford Press New York, NY
188. K.E. Bruscia Defining Music Therapy (2nd ed.) 1998 Barcelona Publishers Gilsum, NH 20
189. S.B. Hanser, S.E. Mandel The effects of music therapy in cardiac healthcare W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 320 330
190. A.R. Hirsch Aromatherapy in cardiac conditions W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 300 319
191. T.R. Stein, M. Oz Integrative medicine in cardiothoracic surgery W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 398 414
192. R. LaForge Mind-body fitness encouraging prospects for primary and secondary prevention J Cardiovasc Nurs 11 1997 53 65
193. P.S. Raju, K.V. Prasad, R.Y. Venkata Influence of intensive yoga training
194. S. Sundar, S.K. Agrawal, V.P. Singh Role of yoga in management of essential hypertension Acta Cardiol 39 1984 203 208
195. D. Ornish, L.W. Scherwitz, J.H. Billings Intensive lifestyle changes for reversal of coronary heart disease JAMA 280 1998 2001 2007
196. S.C. Manchanda, R. Narang, K.S. Reddy Retardation of coronary atherosclerosis with yoga lifestyle intervention J Assoc Physicians India 48 2000 687 694
197. R. Jahnke Qigong and tai chi traditional Chinese health promotion practices in the prevention and treatment of cardiovascular disease W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 204 219
198. K.S. Channer, D. Barrow, R. Barrow Changes in haemodynamic parameters following Tai Chi Chuan and aerobic exercise in patients recovering from acute myocardial infarction Postgrad Med J 72 1996 349 351
199. J.C. Tsai, W.H. Wang, P. Chan The beneficial effects of Tai Chi Chuan on blood pressure and lipid profile and anxiety status in a randomized controlled trial J Altern Complement Med 9 2003 747 754
200. R.E. Taylor-Piliae Tai Chi as an adjunct to cardiac rehabilitation exercise training J Cardiopulm Rehabil 23 2003 90 96
201. C. Lan, S.Y. Chan, M.K. Wong The effect of Tai Chi on cardiorespiratory function in patients with coronary artery bypass surgery Med Sci Sports Exerc 31 1999 634 638
202. G.Y. Yeh, M.J. Wood, B.H. Lorell Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure a randomized controlled trial Am J Med 117 2004 541 548
203. S. Gerson Ayurveda The Ancient Indian Healing Art 1st ed. 1993 Elements Books Ltd Boston, MA (Reprinted 1998)
204. R. Mamtani, R. Mamtani Ayurveda and yoga in cardiovascular diseases W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 168 181
205. V. Lad An introduction to Ayurveda Altern Ther 1 1995 57
206. Alternative Medicine-Expanding Medical Horizons A Report to the NIH on Alternative Medical Systems and Practices in the US 1992
207. L.C.N. Hole Heart Qi and the heart of healing Qigong for the prevention and treatment of cardiac diseases W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 182 203
208. Waya Ai Gvhdi Native American healing for the heart W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 220 231
209. S. Hahnemann Organon of Medicine J. Kunzli A. Naude P. Pendle V.E. Tyler The Therapeutic Use of Phytomedicinals 6th ed. 1982 JP Tarcher Los Angeles, CA
210. J.P. Vandenbroucke, A.J.M. de Craen Alternative medicine A "mirror image" for scientific reasoning in conventional medicine Ann Intern Med 135 2001 507
211. D.T. Reilly, M.A. Taylor, C. McSharry Is homeopathy a placebo response? Controlled trial of homeopathic potency, with pollen in hay fever as model Lancet 2 1986 881
212. M. Shipley, H. Berry, G. Broster Controlled trial of homeopathic treatment of osteoarthritis Lancet 1 1983 97
213. R.D. Whitmont, R. Mamtani Homeopathy with a special focus on treatment of cardiovascular disease W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 232 247
214. E.L. DiGiovanna, D.J. Marinke, D.J. Dowling Introduction to osteopathic medicine E.L. DiGiovanna S. Schiowitz An Osteopathic Approach to Diagnosis and Treatment 2nd ed. 1997 Lippincott-Raven New York, NY 2 13
215. A.J. Spiegel, J.D. Capobianco Osteopathic manipulative medicine in the treatment of hypertension W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 248 258
216. A.J. Spiegel, J.D. Capobianco, A. Kruger Osteopathic manipulative medicine in the treatment of hypertension. An alternative, conventional approach Heart Dis 5 2003 272 278
217. G.A. Ulett, J. Han, S. Han Traditional and evidence-based acupuncture history, mechanism, and present status South Med J 91 1998 1115 1120
218. World Health Organization A proposed standard international acupuncture nomenclature report of WHO scientific group 1991 World Health Organization Geneva
219. B. Pomeranz Scientific basis of acupuncture V.E. Tyler B. Pomeranz Acupuncture Textbook and Atlas 1987 Springer-Verlag Berlin
220. S. Altman Techniques and instrumentation Probl Vet Med 4 1 1992 66 87
221. A. Schlager, T. Offer, I. Baldissera Laser stimulation of acupuncture point P6 reduces postoperative vomiting in children undergoing strabismus surgery Br J Anaesth 81 1998 529 532
222. M. Weintraub Alternative and Complementary Treatment in Neurologic Illness 2001 Churchill New York
223. J.C. Longhurst Central and peripheral neural mechanisms of acupuncture in myocardial ischemia Intl Congress Series 1238 2002 79 87
224. R. Mamtani, W.H. Frishman Acupuncture in cardiovascular diseases W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 260 273
225. T. Williams, K. Mueller, M.W. Cornwall Effect of acupuncture-point stimulation on diastolic blood pressure in hypertensive patients a preliminary study Phys Ther 71 1991 523 529
226. A. Richter, J. Herlitz, A. Hjalmarson Effect of acupuncture in patients with angina pectoris Eur Heart J 12 1991 175 178
227. Y. Kurono, M. Egawa, T. Yano, K. Shimoo The effect of acupuncture on the coronary arteries as evaluated by coronary angiography a preliminary report Am J Chin Med 30 2002 387 396
228. NIH Consensus Development Conference Statement Online 1997. Acupuncture. Available at: http://odp.od.nih.gov/consensus/cons/107/107_statement.html. Accessed February 10, 2004.
229. J.C. Longhurst Acupuncture's beneficial effects on the cardiovascular system Prev Cardiol 1 1998 21 33
230. E. Calenda, S. Fleck Therapeutic massage and Asian bodywork W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 369 383
231. L.Z.Y.X. Song, G.E.R. Schwartz, L.G.S. Russek Heart-focused attention and heart-brain synchronization energetic and physiological mechanisms Altern Ther 4 5 1998 44 62
232. W.A. Tiller, R. McCraty, M. Atkinson Cardiac coherence a new noninvasive measure of autonomic nervous system order Altern Ther Health Med 2 1 1996 52 65
233. J.E. Spence, M.A. Olson Quantitative research on therapeutic touch An integrated review of the literature 1985-1995 Scand J Caring Sci 11 1997 183 190
234. P. Heidt Effect of therapeutic touch on anxiety level of hospitalized patients Nurs Res 30 1980 32 37
235. M.E. McNamara, D.C. Burnham, C. Smith The effects of back massage before diagnostic cardiac catheterization Altern Ther Health Med 9 2003 50 57
236. J.P. Delaney, K.S. Leong, A. Watkins The short-term effects of myofascial trigger point massage therapy on cardiac autonomic tone in healthy subjects J Adv Nurs 37 2002 364 371
237. J. Hanley, P. Stirling, C. Brown Randomised controlled trial of therapeutic massage in the management of stress Br J Gen Pract 53 2003 20 25
238. D.A. Bisson Reflexology W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 331 341
239. M.I. Weintraub, W.H. Frishman Magnetic biostimulation energy therapy W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, OM 384 389
240. M.I. Weintraub Magnetotherapy historical background with a stimulating future Crit Rev Phys Rehab Med 16 2004 95 108
241. M. Keast, K. Adamo The Finnish sauna bath and its use in patients with cardiovascular disease J Cardiopulmonary Rehabil 20 2000 225 230
242. M. Hannuksela, S. Ellahham Benefits and risks of sauna bathing Am J Med 110 2001 118 126
243. J. Hasan, M.J. Karvonen, P. Piironen Special review. Part I. Physiological effects of extreme heat as studied in the Finnish "sauna" bath Am J Phys Med 45 1966 296 314
244. J. Hasan, M.J. Karvonen, P. Piironen Special review. Part II. Physiological effects of extreme heat as studied in the Finnish "sauna" bath Am J Phys Med 46 1967 1226 1246
245. J. Leppaluoto, M. Tuominen, A. Vaananen Some cardiovascular and metabolic effects of repeated sauna bathing Acta Physiol Scand 128 1986 77 81
246. H. Davies Cardiovascular effects of the sauna Am J Phys Med 54 1975 178 185
247. A. Eisalo, O.J. Luurila The Finnish sauna bath and cardiovascular diseases Ann Clin Res 20 1988 267 270
248. Y. Nguyen, N. Naseer, W.H. Frishman Sauna as a therapeutic option for cardiovascular disease W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 342 349
249. Diagnostic and therapeutic technology assessment chelation therapy JAMA 250 1983 672
250. E. Olszewer, J.P. Carter EDTA chelation therapy a retrospective study of 2870 patients J Adv Med 2 1989 197 211
251. N.E. Clarke, C.N. Clarke, R.F. Mosher The "in vivo" dissolution of metastatic calcium an approach to atherosclerosis Am J Med Sci 229 1955 142 149
252. D.M. Eisenberg, R.B. Davis, S.L. Ettner Trends in alternative medicine use in the United States, 1990-1997; results of a follow-up national survey JAMA 280 1998 1569 1575
253. L.T. Chappell, J.P. Stahl The correlation between EDTA chelation therapy and improvement in cardiovascular function a meta-analysis J Adv Med 6 1993 139 160
254. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 33:2092-190 (published erratum 1999;34:314).
255. Cranton EM. Laguna Hills: American College of Advancement in Medicine, 1989.
256. W.H. Frishman, A. Retter, J. Misailidis Innovative pharmacologic approaches to the treatment of myocardial ischemia W.H. Frishman E.H. Sonnenblick D.A. Sica Cardiovascular Pharmacotherapeutics 2nd ed. 2003 McGraw-Hill New York, NY 655 690
257. W.H. Frishman, A.I. Wolff Chelation therapy W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies in Cardiovascular Disease 2005 Elsevier St. Louis, MO 288 299
258. W.H. Frishman Chelation therapy for coronary artery disease panacea or quackery? (editorial) Am J Med 111 2001 729 730
259. M.L. Knudtson, D.G. Wyse, P.D. Galbraith Chelation therapy for ischemic heart disease. A randomized, controlled trial JAMA 287 2002 481 486
260. T.J. Anderson, J. Hubacek, G. Wyse Effect of chelation therapy on endothelial function in patients with coronary artery disease PATCH substudy J Am Coll Cardiol 41 2003 420 425
261. C. Holden Alternative Medicine. NIH trial to test chelation therapy Science 297 2002 1109
262. NIH News release: NIH Launches large clinical trial on EDTA chelation therapy for coronary artery disease. http://nccam.nih.gov/news/2002/chelation/ pressrelease.htm.
263. Clinical Trial: Trial to assess chelation therapy. www.clinicaltrials. gov/ct.
264. A.I. Wolff, W.H. Frishman Animal-assisted therapy and cardiovascular disease W.H. Frishman M.I. Weintraub M. Micozzi Complementary and Integrative Therapies for Cardiovascular Disease 2005 Elsevier St. Louis, MO 362 368
265. V. Voith Attachment of people to companion animals Vet Clin North Am: Small Anim Pract 15 1985 289 295
266. M.B. Marx, T.F. Stallones, J.R. Garrity Demographics of pet ownership among US adults 21-64 years of age Anthrozoos 2 1 1988 33 37
267. G.M. Francis Loneliness measuring the abstract Intl J Nurs Studies 13 1976 153 160
268. Delta Society Standard of Practice for Animal Assisted Activities and Therapy 1996 Delta Society Renton, WA
269. E.A. Bueno, R. Mamtani, W.H. Frishman Alternative approaches to the medical management of angina pectoris. Acupuncture, electrical nerve stimulation, and spinal cord stimulation Heart Dis 3 2001 236 241
270. M.C. Kim, K. Kini, S.K. Sharma Refractory angina pectoris. Mechanism and therapeutic options J Am Coll Cardiol 39 2002 923 934
271. T. Eliasson, L.-E. Augustinsson, C. Mannheimer Spinal cord stimulation in severe angina pectoris-presentation of current studies, indications and clinical experience Pain 65 1996 169 179
272. C. De Landsheere, C. Mannheimer, A. Habets Effect of spinal cord stimulation on regional myocardial perfusion assessed by positron emission tomography Am J Cardiol 69 1992 1143 1149
273. O.A. Latif, S.S. Nedelkovic, L. Warner Stevenson Spinal cord stimulation for chronic intractable angina pectoris a unified theory on its mechanism Clin Cardiol 24 2001 533 541
274. T. Eliaason, C. Mannheimer, F. Waagstein Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris Cardiology 89 1998 170 177
275. D.A. Marshall, E. Walizer, M.N. Vernalis Optimal healing environments for chronic cardiovascular disease J Alt Comp Med 10 suppl 1 2004 S147 S155